Vaccinex Hopes To Bring Pepinemab Forward After Alzheimer’s Results
The company presented what it called positive topline Phase Ib/II data for the SEMA4D-targeting monoclonal antibody in Alzheimer’s and said it is looking for a larger partner.
The company presented what it called positive topline Phase Ib/II data for the SEMA4D-targeting monoclonal antibody in Alzheimer’s and said it is looking for a larger partner.